Vesugen (KED)

Substance: Lys-Glu-Asp (synthetic tripeptide) · Target tissue: Endothelium / blood vessels

Endothelium-targeted tripeptide; note the same KED sequence is marketed under different organ claims (Livagen = liver, Vesugen = vessels) — a red flag for tissue specificity.

Extract counterpart: None established — this compound exists only as a defined synthetic fragment.

Matched publications in database: 4 (EXTRACT 0, SYNTHETIC 3, EXTRACT→SYN 0)

Extract vs synthetic gap: the human outcome data (including the 266-patient mortality cohort) was collected on extracts; vendors sell synthetic fragments. No head-to-head trial exists — evidence does not transfer between them. Details →

Khavinson studies (4 matched, 2015–2020)

Keyword-filtered from the 472-publication database (khavinson.info). EXTRACT/SYNTHETIC tags are title-text heuristics — verification is on the reader. Full tag legend: evidence-tiers.html

[63] Khavinson V.Kh., Tarnovskaya S.I., Linkova N.S., Gutop E.O., Elashkina E.V. Epigenetic Aspects of Peptidergic Regulation of Vascular Endothelial Cell Proliferation in Aging. // Advances in Gerontology. – 2015. – Vol. 5, No 4. – P. 219-224. (2015)untag [PDF]
[1] Ilina A., Kraskovskaya N., Linkova N., Khavinson V. KED peptide prevents synaptic contacts elimination of hippocampus neurons in an in vivo Alzheimer’s disease models. // Hybrid conference “Systems biology and systems physiology: regulation of biological networks”. – Estonia, Tallinn. – 25-27.08.2021. – Abstr. – P. 23-24. (n.d.)syn [PDF]
[3] [Khavinson V., Linkova N., Ashapkin V., Shilovsky G., Vanuyshin B. KE and KED peptides regulate PARP and SIRT gene expression during replicative and stationary human mesenchymal stem cells aging. // Hybrid conference “Systems biology and systems physiology: regulation of biological networks”. – Estonia, Tallinn. – 25-27.08.2021. – Abstr. – P. 8.](https://khavinson.info/assets/files/pdf/ottisk-tez- (n.d.)syn [PDF]
[6] [Caputi S., Sinjari B., Diomede F., Trubiani O., Mironova E., Khavinson V. The effect of KED tripeptide on neuronal differentiation of human gingival mesenchymal stem cells. // International Symposium of Experts “Regenerative medicine and ageing”. – UAE, Dubai. – 01-02.02.2020. – Abstr. Book. – P. 11.](https://khavinson.info/assets/files/skan/the-effect-of-ked-tripeptide-on-neuronal-differentiatio (2020)syn [PDF]

Independent (non-Khavinson) studies

None catalogued. To date there are zero independent Western human trials of any Khavinson compound, in any year. Independent in-vitro data exists for Epitalon only (two 2025 studies). If a study belongs here, add it to non-khavinson-research.json and rebuild.

Reddit meta-scrape

No Reddit community discussion exists for this compound. This is honest reporting — the peptide has essentially zero anecdotal footprint in the biohacking community. Absence of anecdotes is not evidence of safety or efficacy, but it does mean there is no community-level signal to analyze.

Measurement protocol — concrete testable endpoints

Endothelial function testing (flow-mediated dilation), vascular reactivity.

All endpoints on one page: measurement-protocols.html · Evidence-tier legend: evidence-tiers.html

← Livagen (KED) Directory Chonluten (EDG) →